Emerging Immunotherapies & Novel Therapeutics in Endometrial Cancer

Activity Overview

The GOG Foundation, Inc. presents the Emerging Immunotherapies & Novel Therapeutics in Endometrial Cancer, an Independent Satellite Symposium.  The GOG Foundation, Inc. and GOG Partners physician leadership will provide an educational symposium to physicians to increase awareness and the latest practice changing treatment options in endometrial cancer.  Our expert leaders will share the emerging data and outline how to integrate these treatments into clinical practice and mitigate toxicity.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: Eisai Inc. and Merck.

Target Audience

The target audience for this activity is community and academic gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other providers who treat patients with gynecologic malignancies.

Learning Objectives

Upon completion of the activities in this series, learners will demonstrate:

Increased knowledge regarding:

    • The key clinical trial data for newer therapies in advanced and recurrent endometrial cancer
    • The current investigational agents and regimens under evaluation for early, advanced, and recurrent endometrial cancer

Greater competence related to:

      • Selecting therapies and treatments for women with advanced and recurrent endometrial cancer
      • Reducing treatment related toxicities and proactively managing side effects.

Greater confidence in their ability to:

    • Counsel patients with endometrial cancer on available therapies

Faculty


Dr. Bradley Monk

Dr. Tashanna Myers

Dr. Brian Slomovitz

Dr. Angeles Secord

Agenda & Presentation Materials

Emerging Immunotherapies & Novel Therapeutics in Endometrial Cancer, an Independent Satellite Symposium

Presented on Wednesday, August 11, 2021, 6:00 pm – 7:15 pm ET

 

To access the recording of this symposium, please click the button below.  Once you have completed the registration, a confirmation email will be sent to the email address you provide and will include a link to access the recording.  To view the presentation slides, you may click the View Presentation links in the agenda below.

Register To Access the Symposium Recording

 

6:00 pm – 6:07 pm
Welcome & Introduction
Bradley Monk, MD, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph’s Hospital Phoenix, Arizona, USA
View Presentation
6:07 pm – 6:25 pm
The Current Therapeutic Landscape in Endometrial Cancer
Tashanna Myers, MD, Division Chief Gynecologic Oncology, University of Massachusetts School of Medicine- Baystate, Springfield, Massachusetts, USA
View Presentation
6:25 pm – 6:43 pm
Emerging Therapies and Clinical Trials
Brian Slomovitz, MD, Mount Sinai Medical Center, Miami Beach, Florida, USA
View Presentation
6:43 pm – 7:01 pm
Research to Practice – Understanding Treatment Options for Your Patient
Angeles Alvarez Secord, MD, MHSc, Director of Gynecologic Oncology Clinical Trials, Duke Cancer Center Institute, Durham, North Carolina, USA
View Presentation
7:01 pm – 7:11 pm
Treatment and Toxicity 
Bradley Monk, MD, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph’s Hospital Phoenix, Arizona, USA
View Presentation
7:11 pm – 7:15 pm
Wrap Up, Panel Discussion and Final Word
All Session Faculty

Continuing Education

Continuing Education

In support of improving patient care, this activity has been planned and implemented by The GOG Foundation, Inc. (GOG).

Accreditation Statement

The GOG Foundation, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education for physicians.

AMA PRA Category 1 Credits™

The GOG Foundation, Inc. designates this on demand activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Method of Participation

There are no fees for participating in and receiving CME credit for this activity. Participants must: 1) read the educational objectives and faculty disclosures; 2) attend the educational activity; 3) email our educational team at info@gog.org to receive and complete the educational evaluation.

Participants who complete the educational activity and evaluation will receive a certificate of credit.

Disclosure Declaration

In compliance with ACCME regulations, The GOG Foundation, Inc., as the accredited provider of this activity, must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest. All reported conflicts are managed by a designated official to ensure a bias-free presentation. Please see the faculty disclosure for detailed information.

Faculty Disclosures

  • Bradley Monk, MD, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph’s Hospital Phoenix, Arizona, USA
  • Tashanna Myers, MD, Division Chief Gynecologic Oncology, University of Massachusetts School of Medicine- Baystate, Springfield, Massachusetts, USA
  • Brian Slomovitz, MD, Mount Sinai Medical Center, Miami Beach, Florida, USA
  • Angeles Alvarez Secord, MD, MHSc, Director of Gynecologic Oncology Clinical Trials, Duke Cancer Center Institute, Durham, North Carolina, USA

Technical Requirements

You will receive a link to this activity approximately three days prior to the scheduled symposia date. This virtual activity is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers.